- Home
- FluxMPS™ Minimum Essential Medium (MEM), High Glucose w/o L-Glutamine, Sodium Pyruvate, Phenol Red: 1X Liquid
FluxMPS™ Minimum Essential Medium (MEM), High Glucose w/o L-Glutamine, Sodium Pyruvate, Phenol Red: 1X Liquid
FluxMPS™ Minimum Essential Medium (MEM), High Glucose w/o L-Glutamine, Sodium Pyruvate, Phenol Red: 1X Liquid is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) 1X liquid cell culture medium engineered for organ-on-a-chip (OoC), tissue-on-a-chip (ToC), and microphysiological system (MPS) applications. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.
- High glucose (4.5 g/L, 4500 mg/L) formulation with Non-Essential Amino Acids (NEAA) — supports high-energy-demand cell types
- Quadruple-stage filtration train: 0.1 µm → 0.04 µm → 0.1 µm → 0.04 µm, engineered for microchannel-scale flow geometries
- Endotoxin release specification: < 0.05 EU/mL (LAL assay, USP <85> Bacterial Endotoxins Test)
- pH 7.4 (USP <791>); formulated without L-glutamine, without phenol red, and without HEPES — sodium pyruvate present at 110 mg/L
- Bicarbonate-buffered (2200 mg/L NaHCO3); requires an approximately 5.8% CO2 atmosphere to maintain pH 7.4 (validate per cell line/incubator)
- Prepared with Ultrapure Type 1 water (18.2 MΩ·cm); ISO Class 5 aseptic fill & finish
- Manufactured under an ISO 13485:2016 quality management system; final packaging, testing, and customization at Diagnocine Precision, Totowa, NJ
- Custom formulations available — pH, glucose, salts, HEPES, and nutrient composition on request
- Glucose4500 mg/L (4.5 g/L)
- L-GlutamineNot added — supplement as needed
- Sodium Pyruvate110 mg/L
- HEPESNot added
- NEAAIncluded
- pH (USP <791>)7.4
- Osmolality (USP <785>)See CoA
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm → 0.04 µm → 0.1 µm → 0.04 µm
- Shelf Life12 months from date of manufacture, unopened
Engineered where standard media fails
Conventional 0.22 µm-filtered media carry mycoplasma-sized particulates (0.2–0.3 µm), subvisible debris, and endotoxin variation that accumulate inside microchannels — corrupting biosensor readings, triggering inflammation in primary cultures, and shortening device lifetimes. FluxMPS™ addresses these failure modes with a validated four-pass filtration train.
Microchannel-safe purity
0.04 µm final filter retains particulates to sub-mycoplasma size; USP <788> Method 1 (light obscuration) particulate compliance verified per batch.
High-glucose metabolic support
4.5 g/L glucose supports high-energy-demand cell types including HeLa, MCF-7, fibroblasts, and iPSC-derived models in perfusion devices.
Ultrapure-grade water
Prepared with Type 1 water (18.2 MΩ·cm), meeting ASTM D1193 / ISO 3696 Type I purity standards, with trace-metal and organic-carbon (TOC) control.
Low background for imaging
Ultra-low particulate load supports high-content confocal microscopy and biosensor integration. Riboflavin (0.100 mg/L) is a native component and contributes autofluorescence to account for in fluorescence-based assay design.
Rich, stable nutrient profile
NEAA-supplemented formulation plus micro-batch precision ensures comprehensive amino acid coverage for demanding cell culture models.
Customization on demand
pH, glucose, salts, HEPES, and full nutrient composition available on request. Contact support@diagnocine.com.
Quadruple-stage filtration system
FluxMPS™ Minimum Essential Medium (MEM), High Glucose w/o L-Glutamine, Sodium Pyruvate, Phenol Red: 1X Liquid is processed through a validated four-pass filtration train — a repeated prefilter-and-final-filter pair run twice in series — reaching a 0.04 µm final cut-off. This addresses mycoplasma-sized particulates, subvisible debris, and bioburden that single-pass 0.22 µm filtration does not remove.
-
1
0.1 µm Prefiltration I
Removes large particulates, cell debris, and protein aggregates; protects the first 0.04 µm final-filter cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and microaggregates, including mycoplasma-sized organisms (0.2–0.3 µm), that pass through a 0.22 µm filter.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter, protecting the second 0.04 µm final-filter cartridge and providing full train redundancy.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill & finish performed in a validated ISO Class 5 laminar-flow workstation.
Performance vs. conventional media
The four-pass train reaching a 0.04 µm final cut-off delivers approximately 5× cleaner media by particulate count compared to single-pass 0.22 µm filtration, with USP <788> Method 1 (light obscuration) compliance verified on every production lot.
© Diagnocine® — DCP-MEMG-QPRN1X
Designed for next-generation cell culture platforms
FluxMPS™ Minimum Essential Medium (MEM), High Glucose w/o L-Glutamine, Sodium Pyruvate, Phenol Red: 1X Liquid is validated for organ-on-a-chip, cancer biology, stem cell, vascular biology, metabolomics, and live-cell imaging applications where particulate contamination and endotoxin variation are unacceptable.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant of this formulation is available for automated bioreactor and robotic perfusion systems requiring the ultimate particulate exclusion, adding 0.02 µm and 0.01 µm stages after this product's 0.04 µm polish.
- Total Particulate Exclusion: 0.01 µm filtration for nanoscale valve and sensor protection
- Valve & Sensor Protection: prevents particulate-induced blockage in precision fluidic systems
- Extended Perfusion Stability: maintains flow rate consistency across multi-week automated runs
Inquiry Required: Contact support@diagnocine.com to request the 0.01 µm MPS Grade variant.
Micro Physiological System (MPS) & Chip
Ultra-filtered formulation prevents microchannel clogging and maintains laminar flow integrity across complex chip geometries.
Warburg Effect & Metabolic Research
High-glucose base supports Warburg effect studies and glucose uptake assays in cancer cell lines.
iPSC-Derived Models
Ultrapure formulation supports sensitive iPSC differentiation protocols where endotoxin variation causes off-target effects.
Endothelial & Primary Cells
Microchannel-safe purity supports endothelial barrier integrity and TEER measurement in perfusion models.
Metabolic Flux Analysis
High-glucose base enables 13C isotope tracing and glycolytic flux experiments. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium; this formulation contains 2200 mg/L sodium bicarbonate.
Microscopy & Optical Sensing
Ultra-low particulate load supports high-content confocal imaging and biosensor integration; riboflavin (0.100 mg/L) contributes native autofluorescence to account for in fluorescence-based assay design.
Lot-release quality parameters
Every production lot of FluxMPS™ Minimum Essential Medium (MEM), High Glucose w/o L-Glutamine, Sodium Pyruvate, Phenol Red: 1X Liquid undergoes the complete quality-release battery below before shipment.
| Parameter | Specification |
|---|---|
| Formulation | Contains sodium bicarbonate, calcium, magnesium, glucose, and sodium pyruvate; without L-glutamine, phenol red, and HEPES |
| Appearance | Pale-yellow colored, clear solution |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | See CoA |
| Glucose | 4500 mg/L (4.5 g/L) |
| L-Glutamine | Not added |
| Sodium Pyruvate | 110 mg/L |
| Phenol Red | Not added |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth after 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | Compliant |
| Particulate ≥25 µm USP <788> Method 1 | Compliant |
| Water Purity | Ultrapure Type 1, 18.2 MΩ·cm (ASTM D1193 / ISO 3696) |
| Manufacturing std. ISO 13485 | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protected from light |
| Freeze-thaw | Not recommended |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | Approximately 5.8% CO2 (derived from 2200 mg/L NaHCO3 at pH 7.4; validate per cell line/incubator) |
| Parameter | Specification |
|---|---|
| Raw material grade | Cell culture / reagent grade |
| Traceability | Full lot documentation, CoA available |
| Manufacturing QMS | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch precision manufacturing |
| Intended use | For Research Use Only (RUO) |
Full composition (mg/L)
Complete formulation with CAS numbers, reproduced from manufacturer specification. Custom compositions available on request.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 2200.000 |
| Sodium chloride | 7647-14-5 | 6800.00 |
| Sodium phosphate dibasic anhydrous | 7558-79-4 | 122.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| L-Arginine hydrochloride | 1119-34-2 | 126.000 |
| L-Cystine dihydrochloride | 30189-89-0 | 31.300 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 52.000 |
| L-Leucine | 61-90-5 | 52.000 |
| L-Lysine hydrochloride | 657-27-2 | 72.500 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 32.000 |
| L-Threonine | 72-19-5 | 48.000 |
| L-Tryptophan | 73-22-3 | 10.000 |
| L-Tyrosine disodium salt | 69847-45-6 | 51.900 |
| L-Valine | 72-18-4 | 46.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 1.000 |
| D-Ca-Pantothenate | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Niacinamide | 98-92-0 | 1.000 |
| Pyridoxine hydrochloride | 58-56-0 | 1.000 |
| Riboflavin | 83-88-5 | 0.100 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 2.000 |
| D-Glucose | 50-99-7 | 4500.000 |
ISO 13485:2016 manufacturing & compliance
Manufactured under ISO 13485:2016 QMS with final packaging, testing, and customization at Diagnocine Precision in Totowa, New Jersey, USA.
ISO 13485:2016 QMS
Full quality management system certification covering manufacturing, testing, and release for every production lot.
Ultrapure Type 1 Water
All media prepared with 18.2 MΩ·cm resistivity water meeting ASTM D1193 / ISO 3696 Type I purity standards.
ISO Class 5 Fill & Finish
Aseptic filling in validated ISO Class 5 laminar-flow workstations; 21 CFR Part 820 (QMSR) aligned.
Micro-Batch Precision
Small-batch manufacturing ensures lot-to-lot nutrient consistency for reproducible perfusion studies.
Endotoxin — USP <85> BET
LAL assay performed on every manufacturing batch. Release specification: < 0.05 EU/mL.
Particulate — USP <788> Method 1
Light obscuration particle count confirms ≥10 µm and ≥25 µm compliance per batch.
Osmolality — USP <785>
Freezing-point osmometry per USP <785>. Result: See CoA.
Documentation — CoA & Full Lot Records
Certificate of Analysis with full QC panel, traceability, and release signatures for every lot.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-MEMG-QPRN1X (FluxMPS™) compares
Side-by-side comparison against conventional 0.22 µm-filtered MEM High Glucose alternatives.
| Parameter | DCP-MEMG-QPRN1X (FluxMPS™) | Conventional MEM High Glucose (0.22 µm) | Standard MEM High Glucose alternative |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| Formulation | Contains sodium bicarbonate, calcium, magnesium, glucose, and sodium pyruvate; without L-glutamine, phenol red, and HEPES | MEM High Glucose Standard | MEM High Glucose Equivalent |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 stages | 1 stage | 1–2 stages |
| Mycoplasma barrier filtration | check_circle | cancel | cancel |
| Endotoxin (release specification) | FluxMPS™ — < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
Varies by supplier |
| USP particulate compliance | check_circle USP <788> Method 1 | cancel | cancel |
| Water quality | Ultrapure Type 1 (18.2 MΩ·cm) | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | Variable | Variable |
| Microfluidic channel compatibility | check_circle Validated | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation | check_circle On request | cancel | Limited |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ Minimum Essential Medium (MEM), High Glucose w/o L-Glutamine, Sodium Pyruvate, Phenol Red: 1X Liquid and Microfluidics Suitable cell culture media.
Supporting literature
Peer-reviewed publications supporting Microfluidics Suitable ultra-filtered media and microfluidic cell culture applications.
- Huh D et al. (2010). Reconstituting organ-level lung functions on a chip. Science, 328(5986), 1662–1668. doi:10.1126/science.1188302
- Bhatia SN & Ingber DE (2014). Microfluidic organs-on-chips. Nature Biotechnology, 32(8), 760–772. doi:10.1038/nbt.2989
- Eagle H (1959). Amino acid metabolism in mammalian cell cultures. Science, 130(3373), 432–437. doi:10.1126/science.130.3373.432
- Warburg O (1956). On the origin of cancer cells. Science, 123(3191), 309–314. doi:10.1126/science.123.3191.309
- Bhattacharya S et al. (2018). Challenges in maintaining cell viability during microfluidic experiments. Electrophoresis, 39(7), 997–1006. doi:10.1002/elps.201700375
- Zhang YS et al. (2017). Multisensor-integrated organs-on-chips for automated in situ monitoring. PNAS, 114(12), E2293–E2302. doi:10.1073/pnas.1612906114
- Vernetti L et al. (2017). Functional coupling of human microphysiology systems. Scientific Reports, 7, 42296. doi:10.1038/srep42296
- Esch EW et al. (2015). Organs-on-chips at the frontiers of drug discovery. Nature Reviews Drug Discovery, 14(4), 248–260. doi:10.1038/nrd4539
- Zheng F et al. (2021). Organ-on-a-chip systems: microengineering to biomimic living systems. Small, 17(7), 2004175. doi:10.1002/smll.202004175

